Victoza is widely known as a diabetes medication, but many patients also experience weight loss while using it. Here’s how liraglutide changes appetite, digestion, and metabolic health — plus the risks physicians monitor closely.
Some patients stop Ozempic and other weekly GLP-1 drugs despite improved blood sugar results. Persistent nausea, appetite suppression, treatment fatigue, and lifestyle burden may all contribute to long-term discontinuation.
Some patients who switch to Ozempic or Mounjaro eventually return to older GLP-1 drugs like Byetta. Side effects, familiarity, insurance coverage, and treatment routines all influence long-term diabetes medication adherence.
Many patients who once relied on Byetta have transitioned to weekly GLP-1 drugs like Ozempic and Mounjaro. The shift reflects more than convenience — it highlights how injection burden, meal timing, travel logistics, and adherence shape modern diabetes care.
Byetta requires more than correct dosing. Injection timing, refrigeration, travel storage, and handling errors can directly affect medication effectiveness and blood sugar control. Here’s what patients using exenatide need to know.